Abstract
Purpose
Patients with Moyamoya Angiopathy (MMA) require hemodynamic evaluation to assess the risk of stroke. Assessment of cerebral blood flow with [15O]water PET and acetazolamide challenge is the diagnostic standard for the evaluation of the cerebral perfusion reserve (CPR). Estimation of the cerebrovascular reactivity (CVR) by use of breath-hold-triggered fMRI (bh-fMRI) as an index of CPR has been proposed as a reliable and more readily available approach. Recent findings suggest the use of resting-state fMRI (rs-fMRI) which requires minimum patient compliance. The aim of this study was to compare rs-fMRI to bh-fMRI and [15O]water PET in patients with MMA.
Methods
Patients with MMA underwent rs-fMRI and bh-fMRI in the same MRI session. Maps of the CVR gained by both modalities were compared retrospectively by calculating the correlation between the mean CVR of 12 volumes of interest. Additionally, the rs-maps of a subgroup of patients were compared to CPR-maps gained by [15O]water PET.
Results
The comparison of the rs-maps and the bh-maps of 24 patients revealed a good correlation (Pearson’s r = 0.71 ± 0.13; preoperative patients: Pearson’s r = 0.71 ± 0.17; postoperative patients: Pearson’s r = 0.71 ± 0.11). The comparison of 7 rs-fMRI data sets to the corresponding [15O]water PET data sets also revealed a high level of agreement (Pearson’s r = 0.80 ± 0.19).
Conclusion
The present analysis indicates that rs-fMRI might be a promising non-invasive method with almost no patient cooperation needed to evaluate the CVR. Further prospective studies are required.
Keywords: Cerebrovascular reactivity, Resting-state fMRI, Breath-hold fMRI, [15O]water PET, Moyamoya Angiopathy
Introduction
Moyamoya Angiopathy (MMA) is a progressive steno-occlusive arteriopathy of terminal parts of the internal carotid arteries and the circle of Willis [1] resulting in reactive collateralization from new vessels. The most common symptoms are transient ischemic attacks, ischemic strokes, headache, and epilepsy [2–4]. Since no causal treatment to stop the steno-occlusive disease exists, the therapeutic approach consists of surgical revascularization, for example, by bypass surgery between the superficial temporal artery and the middle cerebral artery [5]. If a reduced cerebral perfusion reserve capacity is seen on functional imaging, patients have an increased risk of stroke. Therefore, for the indication of neurosurgical revascularization cerebral perfusion reserve (CPR) must be measured by functional perfusion imaging [6, 7].
Today’s investigative standards of the CPR include nuclear medicine imaging techniques such as [15O]water PET with acetazolamide (ACZ) challenge [8]. Disadvantages are high cost and limited availability due to the requirement of short-lived radiopharmaceuticals. In addition, absolute quantification of cerebral blood flow requires invasive arterial blood sampling, which, however, may be circumvented by semi-quantitative, non-invasive approaches [9, 10]. Although very rare, side effects of the application of ACZ may occur [11]. Functional blood-oxygen-level-dependent (BOLD) fMRI with hypercapnic stimulation provides a more widely available but comparable alternative by measuring the cerebrovascular reactivity (CVR), which is defined as the change in cerebral perfusion in response to a vasodilatory stimulus as an index for the CPR [10]. CO2 is a potent vasodilatory stimulus that leads to increased perfusion in brain tissue with unimpacted CVR [12]. Since the cerebral metabolic rate of oxygen remains constant, the increased perfusion results in an altered ratio of diamagnetic oxy-hemoglobin to paramagnetic deoxy-hemoglobin and causes significant BOLD signal changes [13]. Hypercapnia-triggered fMRI does not require the application of radiopharmaceuticals and is therefore less restricted by contraindications (e.g., pregnancy). Hypercapnia can be achieved by the inhalation of CO2-enriched gas [12, 14–19] or by performing short breath-hold periods [10, 12, 20–23]. The inhalation of CO2-enriched gas mixtures requires experience in handling and monitoring [24] and an MR-compatible gas delivery apparatus [25] that might be not available in every hospital. Breath-holding (bh) is an easily implementable method to achieve hypercapnia and does not require any additional equipment [11, 26, 27], but relies on the patients’ cooperation [11, 12].
Recent findings suggest that resting-state fMRI (rs-fMRI) might be a promising method to estimate the CVR [24, 25, 28–31]. One method uses low-frequency physiological CO2 oscillations during normal breathing as an intrinsic vasoactive stimulus to estimate the CVR [24, 28]. These small fluctuations in arterial CO2 are expected in a frequency range of 0.05 Hz and below [24, 32–34] and attributed to fluctuations in breathing depth, breathing rate, and delayed chemoreflex feedback [33, 35]. The rs-fMRI approach attempts to investigate the BOLD signal response to these global intrinsic CO2 variations attributed to natural variations in respiration. One methodology is to extract BOLD MRI signal components attributed to CO2 fluctuations by means of a suitable frequency band-pass filter and to use the BOLD signal time course of a brain region in which a physiological CVR is expected as a reference region for voxel-wise regression analysis [24, 28]. In this context, rs-fMRI is not used to analyze functional connectivity, such as the default mode network, as in other clinical settings. Rather, the aim is to detect different respiration-induced BOLD signals in brain regions with impaired CVR than in healthy reference regions during natural breathing. Recently, Liu et al. showed that rs-fMRI leads to comparable results as hypercapnia-triggered fMRI by use of CO2-enriched gas inhalation [24].
Breath-hold-triggered BOLD fMRI (bh-fMRI) has been shown to lead to reliable and comparable hemodynamic evaluation of patients with MMA to the diagnostic standard [15O]water PET with ACZ challenge [10, 23]. In this work we aimed to estimate the CVR in patients with MMA by use of rs-fMRI and compared the results to bh-fMRI and to the assessment of the CPR yielded by [15O]water PET with ACZ challenge.
Methods
A retrospective analysis of 27 rs-fMRI and 27 bh-fMRI data sets of 26 patients with MMA was performed. Both fMRI examinations were performed in the same session during routine clinical MRI scans to evaluate cerebral hemodynamics. Main inclusion criteria were angiographically proven MMA with reduced CVR in at least one vascular territory (bh-triggered BOLD signal increase reduced by at least 30% compared to the signal increase of a cerebellar reference region, see below) and no secondary cerebral disease. The data sets of two patients were excluded because no impairment of the CVR was observed. Morphological MR imaging showed lesions in 14 of the patients with MMA. The data sets of these patients were evaluated in a subgroup and compared to the subgroup of data sets with unremarkable morphological imaging. None of the patients included in the study presented with seizures at the time of examination. Data sets of 14 patients before and 11 patients after neurosurgical revascularization were included in this study and evaluated combined and in subgroups. One patient was examined twice, once before and the second time 4 months later after surgical revascularization. General patient data can be seen in Tab. 1. Additionally, in a subgroup of seven patients the rs-fMRI data sets were compared to [15O]water PET with ACZ challenge if these data sets were available. The time period between the MR and the [15O]water PET examination was up to 3 months. The study was approved by the local Ethics Committee.
Table 1.
General patient data | |
---|---|
Mean age (range) | 48 (9–75) |
Female:male ratio | 16:9 |
Bilateral Moyamoya disease | 20 |
Unilateral Moyamoya Angiopathy | 5 |
rs-fMRI data sets | 25 |
bh-fMRI data sets | 25 |
MR imaging before revascularization | 14 |
MR imaging after revascularization | 11 |
MR imaging with lesions | 14 |
MR imaging without lesions | 11 |
PET data sets available | 7 |
MRI data acquisition
All MR images were acquired on a 3-T MR Scanner (Magnetom Skyra, Siemens, Erlangen, Germany). During the examination, subjects were positioned supine on the scanner table. A standard 20-channel head coil was used for imaging. The fMRI data was measured by means of T2*-weighted echo-planar sequences with the following parameters: resting-state fMRI: TR = 2000 ms, TE = 35 ms, matrix 64 × 64, 3-mm slice thickness, 34 slices in interleaved ascending order, FOV = 190 mm, resolution 3.0 × 3.0 × 3.0, echo spacing: 0.58 ms, TA 5:12 min, 153 measurements. Breath-hold fMRI: TR = 3000 ms, TE = 36 ms, matrix 96 × 96, 3-mm slice thickness, 34 slices in interleaved ascending order, FOV = 245 mm, resolution 2.6 × 2.6 × 3.0, echo spacing: 0.58 ms, TA 6:53 min, 135 measurements.
During the rs-task the patients were instructed to lie still and close their eyes without performing any task.
The bh-task involved 60 s of normal breathing, followed by 5 repetitive cycles, each consisting of 9-s end-expiratory breath-hold periods and 60 s of regular breathing. The respiratory instructions were presented visually via a wall-mounted display by use of mirror fixed to the head coil. We used Presentation V20.1 (Neurobehavioral Systems, Berkeley, CA, USA) to present scanner triggered stimuli.
MRI data pre-processing
The MRI data was pre-processed using Statistical Parameter Mapping (SPM12) (https://www.fil.ion.ucl.ac.uk/spm/) running on MATLAB (R2018b (The MathWorks, Inc., Natick, MA; http://www.mathworks.com)). The DICOM images were converted to analyze format in NIfTI (Neuroimaging Informatics Technology Initiative) and then realigned to correct subjects’ head movement, normalized to standard MNI space, segmented into 12 templates [36] (see Fig. 1) to enable good comparability between the rs- and the bh-data, and spatially smoothed by a Gaussian kernel of 12-mm FWHM. The bh-data was slice-timing corrected to equalize the time of image acquisition. The rs-images were not slice-timing corrected because the frequency of resting-state BOLD-signal fluctuations attributed to low-frequency CO2 oscillations is expected to be much lower [24, 32–34] than the MR sample frequency in this study (TR = 2 s). The rs-data was temporally filtered with a band-pass filter of 0.02 to 0.04 Hz, because previous findings of Liu et al. suggest that global resting-state BOLD signal fluctuations within this frequency range correlate best with natural end-tidal CO2 fluctuations [24]. All further processing of the data was performed by using in-house scripts programmed in MATLAB.
Analysis of rs-fMRI data
We used the above-mentioned template of mainly the cerebellum/brainstem (see Fig. 1) and calculated the mean signal time course of this reference region to yield a reference signal time course for voxel-wise correlation analysis. We performed a cross-correlation analysis in which the correlation coefficients between the cerebellar reference time course and the individual voxels’ signal time courses were calculated. The values of the correlation coefficients were displayed as overlays on the normalized standard brains. In exemplary maps generated in this manner, color-coding was applied, with high correlation coefficients represented by warm colors and low correlation coefficients by cold colors. For an individual color-coding, the histogram of all voxels within the cerebellar reference volume was calculated and the 20th percentile of the cerebellar histogram was determined. All voxels within the brain with a correlation coefficient exceeding the 20th percentile of the histogram were colored red. The threshold values of the further color-coding resulted from a gradual subtraction of 0.2 from this individual cerebellar threshold value.
Analysis of bh-fMRI data
The template of mainly the cerebellum was used to calculate the signal time course of each of the five repetitive cycles. This served to check the compliance of the patients in performing the breath-hold periods. For each voxel, the signal time course of the five cycles was calculated and averaged (Fig. 2). The relative BOLD signal change was calculated to adjust for variability in the baseline signal intensity of the echo planar imaging sequence. The signal time course of the cerebellum also served as reference region to manually select the start and the end point of the breath-hold related BOLD response in each patient. For a more detailed description of the procedure and exemplary depictions of the signal time courses we refer to the study of Hauser et al. [10]. Mean relative signal change during the cerebellar BOLD response period was calculated voxel-wise and displayed as overlays on the normalized standard brains. In exemplary maps generated in this manner, color-coding was applied with high values assigned to warm colors and low values to cold colors to enable optimal comparability with the rs-maps. Analogous to the color-coding of the rs-maps, the 20th percentile of the cerebellar histogram was determined as threshold value for the color red. The threshold values of the other colors were calculated by gradually subtracting 10% from this value, resulting in the thresholds 90%, 80%, 70%, etc. of the 20th percentile of the cerebellar histogram.
[15O]water PET with ACZ challenge: data acquisition, processing, and analysis
PET scans (in n = 7 patients; n = 6 preoperative, n = 1 postoperative) were acquired on a Philips Vereos digital PET/CT system (Philips, The Netherlands). We did not absolutely quantify the regional cerebral blood flow (CBF; in terms of ml/min/100 g brain tissue) by continuous arterial blood sampling and kinetic modeling. Instead we used a simplified method to estimate cerebral perfusion reserve (CPR) as proposed by Arigoni et al. [9] and as recently described [10].
After a low-dose CT for attenuation correction, four 4-min scans were acquired per patient. The head position was gently restrained by a tape, carefully monitored, and, if necessary, corrected throughout the procedure by means of reference skin marks and the scanner laser beam. Scans before and after ACZ injection were done in duplicate (10-min interval between [15O]water injections to allow for sufficient decay) under resting conditions (i.e., eyes open and ears unplugged at normal ambient light and noise). A standard dose of 1000 mg ACZ (except in one patient who received 800 mg because of low body weight of 54 kg) was dissolved in 10 ml water for injection and injected immediately after the end of the 2nd baseline scan as an infusion over 5 min. The 3rd PET scan was started 10 min (5 min) after the start (end) of the ACZ infusion. A standard dose of 300 MBq [15O]water (10-ml volume) was administered at the start of each PET scan as a bolus over 3 s into a cubital vein. PET data sets were reconstructed by using a line-of-response time-of-flight ordered subset 3D iterative reconstruction algorithm employing spherically symmetric basis functions (so-called BLOB-OS-TF reconstruction; number of iterations = 3, number of subsets = 11, resulting voxel size = 2.0 × 2.0 × 2.0 mm3) yielding a dynamic sequence of 30 frames (18 × 5 s, 9 × 10 s, and 3 × 20 s) per scan. All datasets were fully corrected (attenuation, scatter, randoms, normalization, and calibration) during iterative reconstruction.
For simplified voxel-wise calculation of CPR maps, all scans of each subject were corrected for motion and integrated over 60 s after arrival of the tracer in the individual patient’s brain [9, 10]. The start time of integration was determined by analyzing the time-activity curve with a whole-brain region of interest (35% of maximum isodensity contour) covering a 5-cm slab at the level of the basal ganglia. Voxel-wise estimate of CPR (CPR map) were calculated using the SISCOM methodology [37]. In brief, the two integral scans before and after ACZ were averaged and then masked using a threshold of 18% of the image maximum (whole-brain segmentation). Voxel-wise signal change (%) from baseline status to the status after ACZ administration was calculated and the resulting parametric map was smoothed (Gaussian filter, 12-mm FWHM) and masked again (see above), yielding the desired CPR map. A customized “UCLA 2” color-scale was used for display of the CPR maps (thresholded symmetrically around zero with the zero transition being marked by three black bins within the 256-bin color-scale). The commercial software packages PMOD (version 3.7; PMOD Technologies LLC, Switzerland) and MATLAB (The MathWorks, Inc., Natick, MA, USA), as well as the freely available Statistical Parametric Mapping (SPM 12, http://www.fil.ion.ucl.ac.uk/spm/) were used for the aforementioned analyses.
Comparative analysis of rs-fMRI with bh-fMRI
We calculated the mean CVR values of the above mentioned 12 VOIs of each patient (rs-fMRI: correlation coefficients, bh-fMRI: mean relative signal change). The correlation between the normalized rs- and bh-maps was calculated with Pearson’s correlation coefficient r, comparing the mean CVR of the 12 VOIs. For each test p < 0.05 was considered statistically significant.
Comparative analysis of rs-fMRI with [15O]water PET
Analogous to the comparison between rs-fMRI and bh-fMRI, a comparative analysis of rs-fMRI with [15O]water PET was performed by calculating the mean CVR and CPR values of the 12 VOIs (rs-fMRI: correlation coefficients, [15O]water PET: mean blood flow changes (%) after ACZ stimulation). The correlation between the normalized rs- and PET-maps was calculated with Pearson’s correlation coefficient r comparing the mean CVR/CPR of the 12 VOIs.
Results
In total, 25 rs-fMRI data sets of 24 patients with MMA were analyzed and compared to the corresponding bh-fMRI data sets and seven of the rs-fMRI data sets were compared to the corresponding [15O]water PET data sets. All imaging data sets were of good quality and no data set had to be excluded from the evaluation. Visual analysis of the cerebellar signal time courses revealed that the breath-hold tasks were accurately performed in all patients and that all data sets could be included in the analysis.
Comparison of rs-fMRI and bh-fMRI
The comparison between the CVR in the investigated VOIs gained by rs-fMRI and bh-fMRI revealed a significant correlation in 21 of 25 data sets (Fig. 3). High correlation coefficients (maximum 0.95) were measured in most patients. Four patients showed low, non-significant correlation coefficients (minimum 0.35). In three of these patients, significant correlation coefficients were detectable when evaluating only 50% of the slices (centrally located in the standardized MNI space). In one patient differences in the signal time courses of the VOIs with physiological and reduced CVR were detectable only during a short time period at the end of the acquisition time. The mean Pearson’s correlation coefficient was 0.71 ± 0.13. A strong correlation could be detected in the preoperative subgroup (mean Pearson’s correlation coefficient 0.71 ± 0.17) as well as in the postoperative subgroup (mean Pearson’s correlation coefficient 0.71 ± 0.11). Comparing the subgroups of patients with lesions (mean Pearson’s correlation coefficient 0.71 ± 0.12) and without lesions (mean Pearson’s correlation coefficient 0.72 ± 0.18), no significant differences in the correlation between rs-fMRI and bh-fMRI were found. Pearson’s correlation coefficient in the subgroup of seven patients with PET data sets available was 0.79 ± 0.21. Exemplary color-coded CVR maps achieved by rs-fMRI and bh-fMRI can be seen in Fig. 4.
Comparison of rs-fMRI and [15O]water PET
In total, seven rs-fMRI data sets and the corresponding [15O]water PET data sets were compared. A strong and significant correlation (maximum 0.95) could be detected in six of seven patients (mean Pearson’s correlation coefficient 0.80 ± 0.19 in all n = 7) (see Fig. 5). Color-coded maps of one case can be seen in Fig. 6. The rs-fMRI data set with weak correlation to [15O]water PET (0.41) (see Fig. 5, patient 7) also correlated weakly to the corresponding bh-fMRI data set (see Fig. 3, patient 25). Compared to [15O]water PET and to bh-fMRI, the CVR deficits in the affected vascular territories of this patient could not be adequately represented by means of rs-fMRI. An analysis of the resting-state BOLD signal time courses of this patient revealed that differences in the signal time courses of the VOIs with physiological and reduced CVR were detectable only during a time period at the end of the data acquisition. In this patient, the amplitude of the BOLD signal changes was relatively high during the whole time period and the signal time courses of all regions showed a high similarity. Since no respiratory monitoring was performed, we can only assume, but it is possible that the patient showed an atypical respiratory pattern, so that the selected frequency band-pass filter was inappropriate in this patient. An analysis of the rs-fMRI data sets of this patient without frequency filtering showed a higher correlation to the corresponding [15O]water PET data sets (Pearson’s correlation coefficient 0.55).
Discussion
In patients with Moyamoya Angiopathy functional perfusion imaging is required to indicate the need for neurosurgical revascularization [6, 7]. Nuclear medicine imaging techniques such as [15O]water PET with ACZ challenge are established diagnostic methods for the assessment of the remaining cerebral reserve capacity and considered as the diagnostic standard [8]. In recent years, non-invasive MR-based diagnostic methods have gained in importance for CVR estimation [8, 11, 12, 18–20, 38–40]. The vasodilatory stimulus can be hypercapnia achieved by breath-holding [11, 12]. Recent studies have demonstrated not only the strong correlation between bh-fMRI and [15O]water PET [10], but also the high longitudinal reproducibility of the procedure in the hemodynamic evaluation of patients with MMA [23]. However, a disadvantage is the dependence on the patients’ cooperation. Latest approaches attempted to exploit natural low-frequency fluctuations in arterial CO2 during normal breathing to estimate the CVR [24, 25, 28, 31, 41]. In this study we compared the new rs-fMRI approach to breath-hold-triggered fMRI in patients with MMA. Additionally, in a subgroup of seven patients, rs-fMRI was compared to [15O]water PET.
In the present analysis of patients with MMA the estimation of the CVR by use of rs-fMRI revealed a good correlation with bh-fMRI (r = 0.71 ± 0.13). Both the comparison of the subgroup of preoperative (r = 0.71 ± 0.17) and postoperative patients (r = 0.71 ± 0.11) correlated strongly. The correlation of the rs-fMRI data sets to the bh-fMRI data sets was independent of the presence (r = 0.71 ± 0.12) or absence of lesions (r = 0.72 ± 0.18) in the patients’ morphological imaging. The comparison of the CVR maps gained by rs-fMRI to the CPR maps gained by [15O]water PET revealed a strong agreement (r = 0.80 ± 0.19), which was comparable to the correlation between rs-fMRI and bh-fMRI in the same subgroup of patients (r = 0.79 ± 0.21).
In this study in most cases rs-fMRI seemed to be sensitive to detect impaired CVR in patients with MMA. Our results suggest that rs-fMRI might have potential in becoming a routine clinical examination after further research [42, 43]. A major advantage of rs-fMRI over externally hypercapnia-triggered fMRI is that the non-invasive procedure requires no complex inhalation and monitoring equipment and minimal patient cooperation. In bh-fMRI examinations, problems could exist when patients have difficulties following precise respiratory instructions, which, for example, ensure that breath-hold periods are performed after expiration [11, 41]. Therefore, rs-fMRI seems to be a widely available diagnostic method, which could be applied in a wide range of clinical examinations especially in patients who are not able to perform breath-hold tasks (e.g., pediatric patients or patients with cognitive impairment). In addition, rs-fMRI might be particularly helpful in estimating the CVR in severely ill patients in whom externally imposed hypercapnia, whether through breath-holding or through the inhalation of CO2-enriched gas, is undesirable. The rs-fMRI approach without manipulation of the CO2 concentration seems to be feasible in nearly all patients that are able to remain in the scanner for several minutes. The estimation of the CVR provides important information not only in patients with MMA [7, 10, 16, 40, 44, 45], but also in other diseases such as carotid artery stenosis [8, 25] and stroke [11, 28, 46].
During the rs-task the low-frequency changes of blood CO2 content attributed to natural variations in respiration are relatively small (2–4 mmHg) [24]. The reason why they seem to be sufficient for estimation of the CVR might be the sigmoidal relationship between the cerebral blood flow and the CO2 partial pressure [47–50]. Accordingly, the CVR, measured as %BOLD signal change/ΔCO2, is greater for small CO2 changes than for larger CO2 changes [50]. It has been shown that even subtle variations in respiratory rate and depth during natural breathing can be associated with significant BOLD signal changes [32, 33, 51]. However, in individual patients the BOLD signal changes induced by natural CO2 fluctuations could be too small to adequately estimate the CVR. This might be one reason why in some cases of this study only a low correlation between the rs-maps and the bh-maps could be measured.
In this study we used the frequency band-pass-filtered BOLD signal time course of the cerebellum as a surrogate of fluctuations in arterial CO2. Employing the cerebellum as a reference region in patients with MMA is a common approach [10, 21] because it is supplied by vertebrobasilar system that is typically unaffected by MMA and therefore represents a region where a physiological hemodynamic response is expected. Nevertheless, there is a risk that the cerebellar BOLD signal fluctuations in the frequency range selected in this study are not exclusively due to CO2 fluctuations, but are also influenced by other mechanisms such as neural activity, blood pressure fluctuations, or scanner noise [24, 33, 51, 52]. The selection of the frequency band-pass filter was based on the results of the study of Liu et al. [24] in which the end-tidal CO2 concentration correlated strongly with BOLD signal fluctuations within the frequency range between 0.02 and 0.04 Hz in healthy subjects. This might be another reason explaining the varying correlation coefficients of the individual patients in our study as it could be possible that this frequency band-pass filter is not equally appropriate in all patients. No doubt, real-time end-tidal measured CO2 might be a more precise regressor and it would enable absolute quantification of the CVR as %BOLD signal change/Δ end-tidal CO2, but it would be accompanied by complex CO2 monitoring and our aim was to investigate a procedure for the estimation of the CVR that is best available and easily feasible.
Another limitation of the simplified approach without absolute CVR quantification used in this study is that it does not allow inter-subject comparison of the CVR values across patients because the levels of the data ranges of the CVR values differ between individuals and a standardization has not yet been established. Further prospective studies might investigate how to increase the sensitivity of rs-fMRI and focus on open questions such as the best fitting reference time course for a voxel-wise cross correlation analysis and the necessary duration of the rs-scans to enable reliable results. In this study we used a relatively short acquisition time (5:12 min). In one patient this time period was not long enough to identify relevant differences between the signal time courses of regions with physiological and reduced CVR, because the differences were detectable only in the end of the acquisition time. Future studies could explore whether the sensitivity of rs-fMRI could be increased by using longer rs-tasks and analyzing exclusively time periods characterized by large variations in the spontaneous breathing pattern and in the BOLD signal time course. In this work, we compared a promising rs-fMRI approach [24, 28] with the diagnostic standard [15O]water PET and a bh-fMRI approach that has been proven to show good reproducibility [23] and very high agreement with [15O]water PET [10], and with which we also had good clinical experience. Nevertheless, there exists not yet a diagnostic standard of hypercapnia-triggered fMRI in Moyamoya diagnostics and other approaches exist [11, 12, 18, 31].
Conclusions
In this work we demonstrated that rs-fMRI provides comparable evaluation of the CVR as bh-fMRI in patients with MMA. Especially in patients that are unable to cooperate fully, the rs-fMRI approach may be a helpful alternative to map CVR, e.g., when hypercapnic gas challenges are not feasible and patients are not able to perform breath-holding. Furthermore, rs-fMRI requires no additional equipment such as CO2 application and monitoring hardware as well as in room computer monitors to display breathing commands. The good agreement with bh-fMRI and [15O]water PET suggests that rs-fMRI is a promising method meriting further research.
Abbreviations
- ACZ
Acetazolamide
- bh
Breath-hold
- BOLD
Blood-oxygen-level-dependent
- CPR
Cerebral perfusion reserve
- CVR
Cerebrovascular reactivity
- MMA
Moyamoya Angiopathy
- rs
Resting-state
Authors’ contributions
Leonie Zerweck, Constantin Roder, Till-Karsten Hauser, and Uwe Klose contributed to the study conception and design. Data acquisition was performed by Leonie Zerweck, Till-Karsten Hauser, Johannes Thurow, Annerose Mengel, and Uwe Klose. Data analysis was performed by Leonie Zerweck, Till-Karsten Hauser, Johannes Thurow, and Uwe Klose. Data interpretation was performed by Leonie Zerweck, Constantin Roder, Till-Karsten Hauser, Marcos Tatagiba, Nadia Khan, Philipp T. Meyer, Ulrike Ernemann, and Uwe Klose. The first draft of the manuscript was written by Leonie Zerweck. Constantin Roder, Till-Karsten Hauser, Johannes Thurow, Annerose Mengel, Marcos Tatagiba, Nadia Khan, Philipp T. Meyer, Ulrike Ernemann, and Uwe Klose commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Funding
No funding was received for this study.
Data availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
Declarations
Declarations
Preliminary results of the manuscript (comparison between rs-fMRI and bh-fMRI data sets in a subgroup of patients, no comparison between rs-fMRI and [15O]water PET) were presented at the 37th Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) (Zerweck L, Hauser TK, Roder C, Klose U. Measuring cerebrovascular reactivity in patients with Moyamoya Disease: Comparison of resting-state BOLD fMRI to breath-hold BOLD fMRI. Book of Abstracts. ESMRMB 2020 Online, 37th Annual Scientific Meeting 2020/09/30–2020/10/02. MAGMA. Oct 2020;33(Suppl 1):S48. https://doi.org/10.1007/s10334-020-00875-z) and the 55th Annual Conference of the German Society for Neuroradiology (Zerweck L, Hauser TK, Roder C, Ernemann U, Klose U. Hemodynamic evaluation of patients with Moyamoya: Comparison of resting-state-fMRI to breath-hold-fMRI. Book of Abstracts. neuroRAD 2020 Virtual 2020/10/06–08. Clinical Neuroradiology. 2020/06/01 2020;30(2):42–42. https://doi.org/10.1007/s00062-020-00951-w) and results will be presented at the 38th Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) and the 56th Annual Conference of the German Society for Neuroradiology.
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethics approval
All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Medical University of Tuebingen.
Consent
Informed consent was obtained from all individual participants included in the study.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Suzuki J, Takaku A. Cerebrovascular “Moyamoya” disease: disease showing abnormal net-like vessels in base of brain. JAMA Neurol. 1969;20:288–299. doi: 10.1001/archneur.1969.00480090076012. [DOI] [PubMed] [Google Scholar]
- 2.Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18:2–11. doi: 10.5853/jos.2015.01627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226–1237. doi: 10.1056/NEJMra0804622. [DOI] [PubMed] [Google Scholar]
- 4.Tarasow E, Kulakowska A, Lukasiewicz A, et al. Moyamoya disease: diagnostic imaging. Pol J Radiol. 2011;76:73–79. [PMC free article] [PubMed] [Google Scholar]
- 5.Khan N, Schuknecht B, Boltshauser E, et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien) 2003;145:1061–1071. doi: 10.1007/s00701-003-0148-5. [DOI] [PubMed] [Google Scholar]
- 6.Roder C, Burkle E, Ebner FH, et al. Estimation of severity of Moyamoya disease with [(15)O]water-positron emission tomography compared with magnetic resonance imaging and angiography. World Neurosurg. 2018;117:e75–e81. doi: 10.1016/j.wneu.2018.05.163. [DOI] [PubMed] [Google Scholar]
- 7.Lee M, Zaharchuk G, Guzman R, et al. Quantitative hemodynamic studies in Moyamoya disease: a review. Neurosurg Focus. 2009;26:E5. doi: 10.3171/2009.1.FOCUS08300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fierstra J, van Niftrik C, Warnock G, et al. Staging hemodynamic failure with blood oxygen-level-dependent functional magnetic resonance imaging cerebrovascular reactivity: a comparison versus gold standard ((15)O-)H2O-positron emission tomography. Stroke. 2018;49:621–629. doi: 10.1161/STROKEAHA.117.020010. [DOI] [PubMed] [Google Scholar]
- 9.Arigoni M, Kneifel S, Fandino J, et al. Simplified quantitative determination of cerebral perfusion reserve with H2(15)O PET and acetazolamide. Eur J Nucl Med. 2000;27:1557–1563. doi: 10.1007/s002590000319. [DOI] [PubMed] [Google Scholar]
- 10.Hauser TK, Seeger A, Bender B, et al. Hypercapnic BOLD MRI compared to H2(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya disease. Neuroimage Clin. 2019;22:101713. doi: 10.1016/j.nicl.2019.101713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Urback AL, MacIntosh BJ, Goldstein BI. Cerebrovascular reactivity measured by functional magnetic resonance imaging during breath-hold challenge: a systematic review. Neurosci Biobehav Rev. 2017;79:27–47. doi: 10.1016/j.neubiorev.2017.05.003. [DOI] [PubMed] [Google Scholar]
- 12.Fierstra J, Sobczyk O, Battisti-Charbonney A, et al. Measuring cerebrovascular reactivity: what stimulus to use? J Physiol. 2013;591:5809–5821. doi: 10.1113/jphysiol.2013.259150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kastrup A, Li TQ, Takahashi A, et al. Functional magnetic resonance imaging of regional cerebral blood oxygenation changes during breath holding. Stroke. 1998;29:2641–2645. doi: 10.1161/01.str.29.12.2641. [DOI] [PubMed] [Google Scholar]
- 14.Conklin J, Fierstra J, Crawley AP, et al. Impaired cerebrovascular reactivity with steal phenomenon is associated with increased diffusion in white matter of patients with Moyamoya disease. Stroke. 2010;41:1610–1616. doi: 10.1161/STROKEAHA.110.579540. [DOI] [PubMed] [Google Scholar]
- 15.Donahue MJ, Ayad M, Moore R, et al. Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease. J Magn Reson Imaging. 2013;38:1129–1139. doi: 10.1002/jmri.24070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Han JS, Abou-Hamden A, Mandell DM, et al. Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke. 2011;42:3047–3054. doi: 10.1161/STROKEAHA.111.615955. [DOI] [PubMed] [Google Scholar]
- 17.Mutch WA, Mandell DM, Fisher JA, et al. Approaches to brain stress testing: BOLD magnetic resonance imaging with computer-controlled delivery of carbon dioxide. PLoS One. 2012;7:e47443. doi: 10.1371/journal.pone.0047443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pellaton A, Bijlenga P, Bouchez L, et al. CO2BOLD assessment of moyamoya syndrome: validation with single photon emission computed tomography and positron emission tomography imaging. World J Radiol. 2016;8:887–894. doi: 10.4329/wjr.v8.i11.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Liu P, Welch BG, Li Y, et al. Multiparametric imaging of brain hemodynamics and function using gas-inhalation MRI. Neuroimage. 2017;146:715–723. doi: 10.1016/j.neuroimage.2016.09.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bright MG, Murphy K. Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance. Neuroimage. 2013;83:559–568. doi: 10.1016/j.neuroimage.2013.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dlamini N, Shah-Basak P, Leung J, et al. Breath-hold blood oxygen level-dependent MRI: a tool for the assessment of cerebrovascular reserve in children with Moyamoya disease. AJNR Am J Neuroradiol. 2018;39:1717–1723. doi: 10.3174/ajnr.A5739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zerweck, L., Hauser, T.-K., Roder, C., et al. (2020) Investigation of the BOLD-based MRI signal time course during short breath-hold periods for estimation of the cerebrovascular reactivity. SN Comprehensive Clinical Medicine: p. 1551–1562.
- 23.Roder, C., Klose, U., Hurth, H., et al. (2021) Longitudinal reproducibility of CO2-triggered BOLD MRI for the hemodynamic evaluation of adult patients with Moyamoya angiopathy. Cerebrovasc Dis: p. 1–7. [DOI] [PubMed]
- 24.Liu P, Li Y, Pinho M, et al. Cerebrovascular reactivity mapping without gas challenges. Neuroimage. 2017;146:320–326. doi: 10.1016/j.neuroimage.2016.11.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Liu P, De Vis JB, Lu H. Cerebrovascular reactivity (CVR) MRI with CO2 challenge: a technical review. Neuroimage. 2019;187:104–115. doi: 10.1016/j.neuroimage.2018.03.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pillai JJ, Mikulis DJ. Cerebrovascular reactivity mapping: an evolving standard for clinical functional imaging. AJNR Am J Neuroradiol. 2015;36:7–13. doi: 10.3174/ajnr.A3941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kastrup A, Kruger G, Neumann-Haefelin T, et al. Assessment of cerebrovascular reactivity with functional magnetic resonance imaging: comparison of CO(2) and breath holding. Magn Reson Imaging. 2001;19:13–20. doi: 10.1016/s0730-725x(01)00227-2. [DOI] [PubMed] [Google Scholar]
- 28.Taneja K, Lu H, Welch BG, et al. Evaluation of cerebrovascular reserve in patients with cerebrovascular diseases using resting-state MRI: a feasibility study. Magn Reson Imaging. 2019;59:46–52. doi: 10.1016/j.mri.2019.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wu J, Dehkharghani S, Nahab F, et al. The effects of acetazolamide on the evaluation of cerebral hemodynamics and functional connectivity using blood oxygen level-dependent MR imaging in patients with chronic steno-occlusive disease of the anterior circulation. AJNR Am J Neuroradiol. 2017;38:139–145. doi: 10.3174/ajnr.A4973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Liu P, Liu G, Pinho MC, et al. Cerebrovascular reactivity mapping using resting-state BOLD functional MRI in healthy adults and patients with Moyamoya disease. Radiology. 2021;299:419–425. doi: 10.1148/radiol.2021203568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Golestani AM, Wei LL, Chen JJ. Quantitative mapping of cerebrovascular reactivity using resting-state BOLD fMRI: validation in healthy adults. Neuroimage. 2016;138:147–163. doi: 10.1016/j.neuroimage.2016.05.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Birn RM, Diamond JB, Smith MA, et al. Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. Neuroimage. 2006;31:1536–1548. doi: 10.1016/j.neuroimage.2006.02.048. [DOI] [PubMed] [Google Scholar]
- 33.Wise RG, Ide K, Poulin MJ, et al. Resting fluctuations in arterial carbon dioxide induce significant low frequency variations in BOLD signal. Neuroimage. 2004;21:1652–1664. doi: 10.1016/j.neuroimage.2003.11.025. [DOI] [PubMed] [Google Scholar]
- 34.Modarreszadeh M, Bruce EN. (1994) Ventilatory variability induced by spontaneous variations of PaCO2 in humans. J Appl Physiol. 1985;76:2765–2775. doi: 10.1152/jappl.1994.76.6.2765. [DOI] [PubMed] [Google Scholar]
- 35.Van den Aardweg JG, Karemaker JM. Influence of chemoreflexes on respiratory variability in healthy subjects. Am J Respir Crit Care Med. 2002;165:1041–1047. doi: 10.1164/ajrccm.165.8.2104100. [DOI] [PubMed] [Google Scholar]
- 36.Tatu L, Moulin T, Bogousslavsky J, et al. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50:1699–1708. doi: 10.1212/wnl.50.6.1699. [DOI] [PubMed] [Google Scholar]
- 37.O'Brien TJ, O'Connor MK, Mullan BP, et al. Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun. 1998;19:31–45. doi: 10.1097/00006231-199801000-00006. [DOI] [PubMed] [Google Scholar]
- 38.Mazerolle EL, Ma Y, Sinclair D, et al. Impact of abnormal cerebrovascular reactivity on BOLD fMRI: a preliminary investigation of moyamoya disease. Clin Physiol Funct Imaging. 2018;38:87–92. doi: 10.1111/cpf.12387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.van Niftrik CH, Piccirelli M, Bozinov O, et al. Fine tuning breath-hold-based cerebrovascular reactivity analysis models. Brain Behav. 2016;6:e00426. doi: 10.1002/brb3.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lehman VT, Cogswell PM, Rinaldo L, et al. Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease. Neurosurg Focus. 2019;47:E6. doi: 10.3171/2019.9.FOCUS19616. [DOI] [PubMed] [Google Scholar]
- 41.Jahanian H, Christen T, Moseley ME, et al. Measuring vascular reactivity with resting-state blood oxygenation level-dependent (BOLD) signal fluctuations: a potential alternative to the breath-holding challenge? J Cereb Blood Flow Metab. 2017;37:2526–2538. doi: 10.1177/0271678X16670921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zerweck, L., Hauser, T.K., Roder, C., et al. (2020) Measuring cerebrovascular reactivity in patients with Moyamoya disease: comparison of resting-state BOLD fMRI to breath-hold BOLD fMRI. Book of Abstracts. ESMRMB 2020 Online, 37th Annual Scientific Meeting 2020/09/30-2020/10/02. MAGMA 33: p. S48
- 43.Zerweck L, Hauser TK, Roder C, et al. Hemodynamic evaluation of patients with Moyamoya: comparison of resting-state-fMRI to breath-hold-fMRI. Book of Abstracts. neuroRAD2020 Virtual 2020/10/06-08. Clin Neuroradiol. 2020;30:42–42. [Google Scholar]
- 44.Heyn C, Poublanc J, Crawley A, et al. Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease. AJNR Am J Neuroradiol. 2010;31:862–867. doi: 10.3174/ajnr.A1922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Roder C, Haas P, Fudali M, et al. Neuropsychological impairment in adults with Moyamoya angiopathy: preoperative assessment and correlation to MRI and H2(15)O PET. Neurosurg Rev. 2020;43:1615–1622. doi: 10.1007/s10143-019-01192-3. [DOI] [PubMed] [Google Scholar]
- 46.Geranmayeh F, Wise RJ, Leech R, et al. Measuring vascular reactivity with breath-holds after stroke: a method to aid interpretation of group-level BOLD signal changes in longitudinal fMRI studies. Hum Brain Mapp. 2015;36:1755–1771. doi: 10.1002/hbm.22735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bhogal AA, Siero JC, Fisher JA, et al. Investigating the non-linearity of the BOLD cerebrovascular reactivity response to targeted hypo/hypercapnia at 7T. Neuroimage. 2014;98:296–305. doi: 10.1016/j.neuroimage.2014.05.006. [DOI] [PubMed] [Google Scholar]
- 48.Battisti-Charbonney A, Fisher J, Duffin J. The cerebrovascular response to carbon dioxide in humans. J Physiol. 2011;589:3039–3048. doi: 10.1113/jphysiol.2011.206052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Duffin J, Sobczyk O, McKetton L, et al. Cerebrovascular resistance: the basis of cerebrovascular reactivity. Front Neurosci. 2018;12:409. doi: 10.3389/fnins.2018.00409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Sobczyk O, Battisti-Charbonney A, Fierstra J, et al. A conceptual model for CO(2)-induced redistribution of cerebral blood flow with experimental confirmation using BOLD MRI. Neuroimage. 2014;92:56–68. doi: 10.1016/j.neuroimage.2014.01.051. [DOI] [PubMed] [Google Scholar]
- 51.Birn RM, Smith MA, Jones TB, et al. The respiration response function: the temporal dynamics of fMRI signal fluctuations related to changes in respiration. Neuroimage. 2008;40:644–654. doi: 10.1016/j.neuroimage.2007.11.059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Tong Y, Hocke LM, Frederick BB. Low frequency systemic hemodynamic “noise” in resting state BOLD fMRI: characteristics, causes, implications, mitigation strategies, and applications. Front Neurosci. 2019;13:787. doi: 10.3389/fnins.2019.00787. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author, upon reasonable request.